Court affirms Amgen EPO patents, blocks Roche drug

A U.S. court on Thursday affirmed a jury verdict upholding Amgen Inc patents on its blockbuster anemia drugs, effectively blocking Roche Holding AG from selling a rival drug in the United States, Amgen said.

The details can be read here.